Finerenone improves outcomes in patients with mild-to-moderate kidney disease and diabetes
Finerenone reduces the risk of cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 diabetes. That’s the finding of late breaking research presented in a Hot Line session today at ESC Congress 20211 and published in the New England Journal of Medicine2. Diabetic kidney disease develops in approximately 40% of patients […]
How can I avoid heart disease or stroke?
The European Society of Cardiology (ESC) Guidelines on cardiovascular disease prevention in clinical practice are published online today in European Heart Journal. As much as 90% of the risk of a heart attack, stroke, or peripheral arterial disease (PAD) can be explained by smoking, poor eating habits, lack of physical activity, abdominal obesity, high blood […]
Does CPAP Therapy for Sleep Apnea Really Have Heart Benefits?
Despite the widespread belief that obstructive sleep apnea (OSA) causes cardiovascular events like strokes and heart attacks, there is actually no good evidence that treating OSA lowers the risk of such cardiovascular outcomes. Observational data showing that OSA is associated with cardiovascular outcomes like atrial fibrillation (Afib), stroke, cardiovascular death, and myocardial infarction (MI) have […]
Study identifies DNA signatures linked to heart disease
A new study identifies DNA signatures associated with risk for cardiovascular disease, a discovery that could lead to opportunities for clinical intervention years before symptoms manifest. Based on analyses of data from five large heart cohort studies of diverse populations, the findings are published in the journal JAMA Cardiology. “The science is rapidly advancing in […]
The Pill Can Spell Trouble for Long QTc
Some oral contraceptives were associated with greater cardiovascular risk among women with inherited long QT syndrome (LQTS), a registry study showed. Progestin-only oral contraceptive users had a 2.54-fold higher risk (95% CI 1.09-1.51) of a cardiac event compared with LQTS women not on oral contraceptives in multivariate analysis. Beta-blocker use appeared to mitigate that risk, […]